Compare SNDA & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNDA | PACB |
|---|---|---|
| Founded | 1990 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 501.8M | 567.6M |
| IPO Year | 1997 | 2010 |
| Metric | SNDA | PACB |
|---|---|---|
| Price | $32.55 | $2.25 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $28.00 | $2.00 |
| AVG Volume (30 Days) | 65.0K | ★ 10.8M |
| Earning Date | 11-10-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $327,007,000.00 | $154,584,000.00 |
| Revenue This Year | $25.63 | $6.06 |
| Revenue Next Year | $6.18 | $15.15 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 29.15 | N/A |
| 52 Week Low | $19.34 | $0.85 |
| 52 Week High | $33.50 | $2.73 |
| Indicator | SNDA | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 66.51 | 57.93 |
| Support Level | $32.19 | $2.24 |
| Resistance Level | $33.48 | $2.73 |
| Average True Range (ATR) | 0.80 | 0.21 |
| MACD | -0.08 | 0.05 |
| Stochastic Oscillator | 51.30 | 60.47 |
Sonida Senior Living Inc is an owner operator of senior housing communities in the United States in terms of resident capacity. It provides senior living services to the elderly, including independent living, assisted living, Respite Care and Temporary Care Programs, Home Care Services, and memory care services. The company's objective is to provide value to residents by providing quality senior housing services at reasonable prices. The basic service of the company is comprised of meals, housekeeping, laundry, 24-hour staffing, transportation, social and recreational activities, and healthcare monitoring.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.